HB-adMSCs (allogeneic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HB-adMSCs (allogeneic), covering 2025-12-24 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD) [Phase 2]